TAVR-30

Patients undergoing transcatheter aortic valve replacement (TAVR) are at a higher risk of recurrent healthcare resource utilization due to multiple comorbidities, frailty, and advanced age. The 30-day all-cause readmission rate has been reported at 15-20%. We have devised a simple tool to identify patients at higher risk of 30-day readmission using the Nationwide Readmissions Databases (from January 2013 to September 2015). This simple and easy-to-use risk prediction tool may help identify TAVR patients at increased risk of 30-day readmission, and aid in appropriate transition of care upon discharge and post-discharge follow-up. Note: This app (“App)” provides only information, is not medical or treatment advice and may not be treated as such by the user. As such, this App may not be relied upon for the purposes of medical diagnosis or as a recommendation for medical care or treatment. The information on this App is not a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this App is for general information purposes only